EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS037-02358 
Organism
Homo sapiens 
Tissue/cell
ESC 
Coordinate
chr1:157983500-157985150 
TF binding sites/motifs
Number: 14             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
RFX1MA0509.2chr1:157984087-157984103TGTTGCCATGGCAACA+8.08
RFX1MA0509.2chr1:157984087-157984103TGTTGCCATGGCAACA-8.08
RFX2MA0600.2chr1:157984087-157984103TGTTGCCATGGCAACA+8.18
RFX2MA0600.2chr1:157984087-157984103TGTTGCCATGGCAACA-8.18
RFX5MA0510.2chr1:157984087-157984103TGTTGCCATGGCAACA+8.1
RFX5MA0510.2chr1:157984087-157984103TGTTGCCATGGCAACA-8.1
ZNF263MA0528.1chr1:157984280-157984301TCTCCCACCCTTTACTCCTTC-6.28
ZNF263MA0528.1chr1:157984017-157984038GGGGGAGGGAAGAGAGAGAGA+6.95
ZNF263MA0528.1chr1:157984004-157984025AAAGGAGGGAGGAGGGGGAGG+7.35
ZNF263MA0528.1chr1:157984008-157984029GAGGGAGGAGGGGGAGGGAAG+8.14
ZNF263MA0528.1chr1:157984011-157984032GGAGGAGGGGGAGGGAAGAGA+8.23
ZNF740MA0753.2chr1:157984470-157984483GGGGGGGGGGGGG-6.03
ZNF740MA0753.2chr1:157984468-157984481ATGGGGGGGGGGG-6.07
ZNF740MA0753.2chr1:157984473-157984486GGGGGGGGGGCGG-6.64
Number of super-enhancer constituents: 18             
IDCoordinateTissue/cell
SE_00315chr1:157974956-157984543Adipose_Nuclei
SE_01211chr1:157984123-157984530Adrenal_Gland
SE_01670chr1:157974654-157985670Aorta
SE_03108chr1:157984029-157984470Bladder
SE_26124chr1:157983414-157984486Duodenum_Smooth_Muscle
SE_29957chr1:157983392-157985022Fetal_Muscle
SE_36687chr1:157983761-157984543HMEC
SE_36687chr1:157984921-157991843HMEC
SE_38884chr1:157976105-157985668IMR90
SE_42820chr1:157982936-157984694Lung
SE_45055chr1:157983683-157984207NHLF
SE_45978chr1:157970192-157985524Osteoblasts
SE_46705chr1:157982928-157984067Ovary
SE_46705chr1:157984162-157984483Ovary
SE_47236chr1:157974787-157993863Panc1
SE_49377chr1:157984518-157985453Right_Atrium
SE_50762chr1:157976039-157985489Sigmoid_Colon
SE_68036chr1:157938003-157993230TC32
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1157983668157983800
Enhancer Sequence
AGGTGTGTGT ACACCTCCCG CCGACTAGAA AACTGCCACT TCATCTAGGC TGTCTCCACG 60
GACCTCCCTG CCTCCCCTAC CATTCCCCAC TGCACAGACA AAAATGTCCT TTCTGGGGTG 120
GGGGTGGGAG TAGGGGTGGT GACTTAAGGA GCTTACTGTC CATTAATTGC TAGAGGAAGG 180
TGGTGGTCCC TGGAGGATTT TAGGTGACAC TGCTCCTGGG ACTGTCAGCA GATCCCCCAC 240
CTTCCCTAGA GATGCCCTTG TTTTTCAACC TCTGCCCCCA TCCCTCCTAA GGGGCCTATT 300
CTTGCTGTCA TGGCAACCAG GGGATTAGGA CCAGTTTGGA AGCCCAAAGA TATGGGAGAG 360
GGCTTAGTAA GAAGGCAGGT GGAAGGAGGA AATGAGAGAA TGAGGTGATG ATAAAAAAAC 420
AGAGCTACGT GGGGGAAGTG GAGGGCAACG AGGAAGGTAA AGGGAAGGGG GAGATGAGAG 480
AGACCTCACT AGAGTAAGAG AGAAAAAGGA GGGAGGAGGG GGAGGGAAGA GAGAGAGAGA 540
AACCTCAACT TTTATTTAAA ATCAGAGAGC AGTTGTAAGC CTGGAGTTGT TGCCATGGCA 600
ACAGCAAAGA AAAGAAGATA GAGAGCTTGT GAAGCCATGA AAACCCAATA GGGGTAAATG 660
TTTAAAGCCA GGAACAAAAA CCATTCAGAG ATAATTAAGT AACCGGCCGC AGGTTCCATA 720
CTCCTGCCCA TTGTCCGGGA CTCTGCCTGA GATCCTAGCC TCCTTCCCGT CTTGCCTTCT 780
TCTCCCACCC TTTACTCCTT CCCCTCACTC ACAAGGATTT CAAAGCAGCA GCCAGGGAAC 840
ACCCGACCAC CCTCCCTGTA ATCTTCTTTC CTTTAGCGAG GGACTGACCT GCTTACTCCG 900
GTCCCAGTCC CTTAGACCGA CACTGGGCGA GCTTTCTCTC CTTCACTATT AAGAGAAATA 960
TAGTCTTTAT GGGGGGGGGG GGGCGGGGGG AAGGAGGTTT TAGTCAGATA AATGGAAGAA 1020
CTTCTTGACG CTGAATTGCT ACATGGATAA CTAAGTTGTG GACTTTTCTT TCCTTCCTTG 1080
GATACGACAG GCAAGGCCCA CCTCTGTGTT AACTGCGGCC CTCTAGATCT CTGAATTGCT 1140
AGGATTCTTG GGGTCTTCCT CGGAAGGGGA GGTGCGTTCT CCTCCTTCCG GTGCTTTACT 1200
GGGACTATTT AACTGTGTTT AATGCTACCA CTAATTCCTC TTTGAATGCT TCTTAGGATT 1260
TTTCCAGCAG GCTTAATCTT CCCAAGCCTC AGGATGGCCA CAAGCTAAGC TGATACTTTG 1320
GGGGTTAGGT GTACTCTGAA GAAATTTTTT TTTATTGCCA AAGTACTCTT TTGTTTTTTA 1380
AATGAGTTTC ATAAAGTCAC CTTACTCCTA CCCCAGACAT CACAACAGCT GGCTGGCCCC 1440
TCACCCCATC TCCTTAGGGA AATAATCTTT TGAGTCCTGC CATACCTTCA GTGTCTCCTA 1500
AGAAACTGTG AGTATCAGAG AGGGCTGTGA TGTCCTTTTC TTCCTCTCAT CTCTGATGCA 1560
GTTCTGAACT GGGGGCCAAA ATAGCTAAGT AGGAAGAGTC CTGTTTTGCA CCTGCAGCAC 1620
TCCCTCGCTC CTGCCCGCTG TTATCACCCA 1650